TLab dives into SARS-CoV-2 Research

As a (mostly) computational lab, we count ourselves lucky to continue our work without too much disruption during the pandemic. It is probably because of this situation and the fact that we all are part of a community hit hard by the virus, that we are feeling extra motivated to do what we can to help. These past two weeks have been big for the lab. We now have three manuscripts on SARS-CoV-2 research out for review. These include a paper that replicates a previous finding associating blood groups with infection status, a study that identifies new clinical and genetic risk factors for SARS-CoV-2 outcomes, and a paper that investigates the role of ACE inhibitor exposure on infection rates.

These works were made possible by a lot of hard work from Michael, Undina, Vijendra, and Phyllis.